95
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Kinetics of hepatitis C virus load and hemodialysis: Is there any influence of the reuse of dialysis membrane on HCV viremia?

, , , , , & show all
Pages 190-196 | Received 04 Jul 2011, Accepted 19 Sep 2011, Published online: 08 Nov 2011

References

  • Hayashi J, Nakashima K, Kajiyama W, Noguchi A, Morofugi M, Maeda Y, . Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 1991;134:651–7.
  • Mazzoni A, Innocenti M, Consaga M. Retrospective study on the prevalence of B and non-A, non-B hepatitis in a dialysis unit: 17-year follow-up. Nephron 1992;61:316–7.
  • Rivanera D, Lilli D, Lorino G, Pirozzi V, Cannulla V, Dicuonzo G, . Detection of antibodies to hepatitis C virus in dialysis patients. Eur J Epidemiol 1993;9:55–8.
  • Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002;15:162–71.
  • Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, . Decline of hepatitis C infection in hemodialysis patients in central Brazil: a ten years of surveillance. Mem Inst Oswaldo Cruz 2005;100:345–9.
  • Sesso R, Lopes AA, Thomé FA, Bevilacqua JL, Romão JE, Lugon J. Relatório do Censo Brasileiro de Diálise, 2008. J Bras Nefrol 2008;30:233–8.
  • Stehman-Breen C, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with HCV. Am J Kidney Dis 1998;32:629–34.
  • Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896–902.
  • Kalantar-Zadeh K, Mcallister CJ, Miller LG. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population-based study. Nephrol Dial Transplant 2005;20:1662–9.
  • Di Napoli A, Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S, . Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Am J Kidney Dis 2006;48:629–37.
  • Trevizoli JE, de Paula Menezes R, Ribeiro Velasco LF, Amorim R, de Carvalho MB, Mendes LS, . Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients. Clin J Am Soc Nephrol 2008;3:1385–90.
  • Furusyo N, Hayashi J, Ariyama I, Sawayama Y, Etoh Y, Shigematsu M, . Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000;95:490–6.
  • Okuda K, Yokosuda O. Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4–23 years of follow-up. World J Gastroenterol 2004;10:2209–12.
  • Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, . Chronic hepatitis C infection in patients with end-stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999;94:3576–82.
  • Colter S, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, . Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002;35:191–5.
  • Azevedo HA, Villela-Nogueira CA, Perez RM, Segadas-Soares JA, Takahashi C, Gaburo N, . Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function. J Nephrol 2007;20:609–16.
  • Fabrizi F, Messa P, Martin P. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight. Int J Artif Organs 2009;32:1–11.
  • Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, . What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11:8–13.
  • Miyachi H, Masukawa A, Asai S, Miura T, Tamatsukuri S, Hirose T, . Quantitative assay of hepatitis C virus RNA using an automated extraction system for specific capture with probes and paramagnetic particle separation. J Clin Microbiol 2003;41:572–5.
  • Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289–93.
  • Oliveira Penido JM, Caiaffa WT, Guimarães Penido M, Caetano EV, Carvalho AR, Leite AF, . The seroprevalence of HCV in patients submitted to hemodialysis and health professionals in the state of Minas Gerais, southwest of Brazil. Nefrologia 2008;28:178–85.
  • Taziki O, Espahbodi F. Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi J Kidney Dis Transpl 2008;19:475–8.
  • Halfon P, Khiri H, Feryn JM, Sayada C, Chanas M, Ouzan D. Prospective virological follow-up of hepatitis C infection in a hemodialysis unit. J Viral Hepat 1998;5:115–21.
  • Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, . Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000;35:122–9.
  • Ghany MG, Strader DB, Thomas DL, Seef LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335–74.
  • Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 2001;50(RR-5):1–43.
  • Upadhyay A, Sosa MA, Jaber BL. Single-use versus reusable dialysers: the known unknowns. Clin J Am Soc Nephrol 2007;2:1079–86.
  • Lombardi M, Cerrai T, Dattolo P, Pizzarelli F, Michelassi S, Maggiore Q, . Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 1995;10:578–9.
  • Hayashi H, Okuda K, Yokosuka O, Kobayashi S, Yokozeki K, Ohtake Y, . Adsorption of hepatitis C virus particles onto the dialyzer membrane. Artif Organs 1997;21:1056–9.
  • Valtuille R, Fernández JL, Berridi J, Moretto H, del Pino N, Rendo P, . Evidence of hepatitis C virus passage across dialysis membrane. Nephron 1998;80:194–6.
  • Noiri E, Nakao A, Oya A, Fujita T, Kimura S. Hepatitis C virus in blood and dialysate in hemodialysis. Am J Kidney Dis 2001;37:38–42.
  • Mizuno M, Higuchi T, Yanai M, Kanmatsuse K, Esumi M. Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron 2002;91:235–42.**
  • Kaiser T, Damerow HC, Tenckhoff S, Finger A, Böttcher I, Hafer C, . Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis. J Med Virol 2008;80:1195–201.
  • Decamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: a critical survey. Kidney Int 1993;41: 135–42.
  • Girndt M, Sester U, Sester M, Kaul H, Köhler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999;14:2807–10.
  • Malaponte G, Bevelacqua V, Fatuzzo P, Rapisarda F, Emmanuele G, Travali S, . IL-1β, TNF-α and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age. Nephrol Dial Transplant 2002;17:1964–70.
  • Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, . Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? Am J Kidney Dis 2003;42:143–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.